Timothy Pilla, MD
Vascular Surgery · Woodbury, NJNPI 1023019312
Payments from drug & device makers
Across 123 payments — averaging $78.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$8K
- W. L. Gore & Associates, Inc.$267
- Smith+Nephew$266
- Lifenet Health$230
- Bard Peripheral Vascular, Inc.$147
- Novo Nordisk$116
- plus $487 from 9 others
What the payments were for
- Travel & lodging$4,86450%
- Food & beverage$3,31734%
- Education$1,50916%
- Gifts$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 75 | $8,193 |
| W. L. Gore & Associates, Inc. | 12 | $267 |
| Smith+Nephew | 8 | $266 |
| Lifenet Health | 3 | $230 |
| Bard Peripheral Vascular, Inc. | 6 | $147 |
| Novo Nordisk | 1 | $116 |
| Stryker | 1 | $116 |
| Lemaitre Vascular, Inc. | 4 | $111 |
| Angiodynamics, Inc. | 2 | $46 |
| E.r. Squibb & Sons, L.L.C. | 3 | $45 |
| Terumo Medical Corporation | 2 | $41 |
| Davol Inc. | 2 | $39 |
| Mozarc Medical US LLC | 1 | $39 |
| Johnson & Johnson | 2 | $29 |
| Integra Lifesciences Corporation | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$5,263
- DAVINCI XI$1,500
- Grafix$154
- Oasis$154
- Stravix$154
- TheraGenesis Wound Matrix$123
- Wegovy$116
- ARTIX MT$116
How this compares
$9,706 in reported general payments places this provider in the 60th percentile of 182 vascular surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 19 | $11,380 |
| Cilostazol | 38 | $705 |
| ClopidogrelClopidogrel Bisulfate | 35 | $624 |
| Gabapentin | 18 | $262 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 23 | $193 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Woodbury
- David O'ConnorHackensack$894K
- Steven EliasEnglewood$708K
- Michael WildermanHackensack$386K
- Joseph LombardiPomona$321K
- William BeckermanNew Brunswick$176K
- Neil PoulsenRockaway$148K
- Massimo NapolitanoWayne$147K
- Saum RahimiNew Brunswick$101K
- Laurel HastingsCamden$98K
- Danielle PinedaPomona$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.